Ventyx Biosciences, Inc. (NASDAQ:VTYX) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET

Company Participants

Marty Auster – Chief Financial Officer

Raju Mohan – Founder and Chief Executive Officer

Bill Sandborn – President and Chief Medical Officers

Conference Call Participants

Yasmeen Rahimi – Piper Sandler

Josh Schimmer – Evercore ISI

Michael Yee – Jefferies

Tiago Fauth – Credit Suisse

Sam Slutsky – LifeSci Capital

Jeff Jones – Oppenheimer

Operator

Good day, and thank you for standing by. Welcome to the Ventyx Biosciences First Quarter 2022 Financial Results Conference Call. [Operator Instructions]

I would now like to hand the conference over to your speaker today, Mr. Martin Auster. Please go ahead.

Marty Auster

Thank you, operator. Good afternoon, everyone. Thanks for joining the call today. Welcome to Ventyx Biosciences conference call and webcast we’ll be discussing our first quarter 2022 financial results and providing a business update. As a reminder, the company’s most recent investor presentation can be found on our website at www.ventyxbio.com, under the Investor tab of the News & Events section.

Before we begin today, I’d like to remind everyone that this conference call webcast will contain forward-looking statements about the company, including statements about the timing of commencement, enrollment and completion of clinical trials, the anticipated timing of release of clinical trial data and the expected timeframe for funding operations with current cash, cash equivalents and marketable securities. These statements are subject to risks and uncertainties that could cause actual results to differ. Please note that these forward-looking statements reflect our opinions only as of the date of this call, and we undertake no obligation to revise or publicly release the results of any revisions to these forward-looking statements in light of new information or future events. Factors that could cause actual results or outcomes to differ materially from those expressed or implied by such forward-looking statements are discussed in greater detail in our filings with the Securities & Exchange Commission, including our Form 10-Q for the first quarter of 2022, which we expect to file again this afternoon.

With that, I will hand the call over to Dr. Raju Mohan, Ventyx’s Founder and CEO. Raju, please go ahead.

Raju Mohan

Thanks, Marty, and thanks to everyone for joining our call this afternoon. So, let me briefly run through the conference agenda. We’ll start with a business update and then present an overview of the company’s pipeline, followed by recent highlights. I’m then going to hand the call back to Marty for a brief overview of our first quarter financial results before we open the discussion and the call for Q&A.